Trial Profile
Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Prophylactic Tamsulosin for Postoperative Urinary Retention in Primary Total Hip and Knee Arthroplasty Patients
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 13 Apr 2019
Price :
$35
*
At a glance
- Drugs Tamsulosin (Primary)
- Indications Urinary retention
- Focus Therapeutic Use
- 19 Dec 2018 Status changed from recruiting to discontinued.
- 15 Dec 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2019.
- 15 Dec 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.